$DT

Dynatrace's Subsidiary Prices Private Placement Of $1.25 Billion Of Exchangeable Senior Notes

Dynatrace (DT) said its wholly owned subsidiary Dynatrace LLC priced $1.25 billion of 0.00% exchangeable senior notes due 2031 in a private placement. Notes are exchangeable at 15.5585 DT shares per $1,000 principal. Net proceeds are expected at about $1.227 billion, with proceeds for note hedge costs and a share repurchase. Settlement expected Aug. 20, 2026.

Original reporting
Published Aug 18, 2026, 12:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 18, 2026, 12:47 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$DT
Neutral
medium confidence
Mentioned
$DT
Relevance
7/10
alphai data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$DTNeutralMed
01

Why it matters

Net proceeds are allocated to exchangeable note hedge transactions and a privately negotiated share repurchase, which can affect near-term equity supply/demand and volatility around the exchange mechanics.

02

Market read

This is a concrete capital-raise and capital-return disclosure with defined amounts, exchange rate, and settlement timing.

03

What to watch

Traders should watch the hedge unwind and any future exchange behavior around the 15.5585 initial exchange rate, which can influence volatility into settlement.

Relevance 7/10Novelty 7/10Timing: pre-market today, with settlement expected on Aug 20, 2026

Background

Dynatrace’s subsidiary Dynatrace LLC priced exchangeable senior notes in a private placement, a financing structure that links note exchange to Dynatrace common stock.

Company-level read

Ticker impact

$DTNeutralMedium confidence
Context

Dynatrace priced 0.00% exchangeable senior notes due 2031, with net proceeds used for hedge costs and a share repurchase.

Expected impact

Near-term bias modestly positive from the disclosed repurchase intent, but overall impact likely limited versus broader fundamentals.

Evidence & confidence

The article discloses size, exchange rate, net proceeds, hedge cost allocation, and a specific share repurchase amount, which traders can map to capital return and potential dilution/hedging effects.

Market effects

Exchangeable note issuance with equity-linked hedges is a financing template that can affect sentiment toward software capital returns and balance-sheet risk.

Limited, primarily impacts US-listed Dynatrace credit and equity flows.

Low, as the transaction is company-specific and not described as cross-border regulatory or macro-driven.

Counterpoint

The repurchase is funded partly through exchangeable debt mechanics, so the net equity benefit may be smaller than it appears if exchange features or hedging costs offset it.

Key entities

  • Dynatrace LLC

    Indirect wholly-owned subsidiary that priced the exchangeable senior notes due 2031.

  • Dynatrace, Inc.

    Parent company whose common stock is referenced via the initial exchange rate and whose shares are repurchased.

Related articles

$DTMedAI 8/10

Why is Dynatrace stock climbing today?

Dynatrace shares rose 1.2% in pre-open after Dynatrace LLC priced a $1.25 billion private placement of exchangeable senior notes due Sept. 1, 2031, expected to settle Aug. 20, 2026. The exchange price was about $64.27, a 35% premium to the prior close. Citi raised its target to $65 from $62 (Buy).

$CHTRMed

What’s up with… Charter and Cox, Deutsche Telekom, Globalstar

California’s CPUC conditionally approved Charter Communications and Cox Communications’ $34.5bn cable merger, with FCC approval already in place. Deutsche Telekom agreed to buy Poland’s Fiberhost and Inea for €1bn. Globalstar launched eight LEO satellites under a $327m MDA Space deal. VodafoneThree cited a study claiming UK connectivity confidence issues cost up to £115bn in productivity.

$DTMed

Dynatrace Falls as Investors Weigh $915 Million Arize Deal

Dynatrace (DT) shares fell 3.3% as investors weighed its planned acquisition of Arize, announced Aug. 13. Dynatrace said the $915 million deal includes about $815 million in cash plus replacement equity awards. It expects about 200 bps ARR growth in fiscal 2027, but a 175 bps non-GAAP operating margin dilution, without changing Q2 guidance or its share repurchase program.